Back to 
Savant Capital, LLC
Savant Capital, LLC
AMRX
Showing 0 of 2 quarters
Position history for Savant Capital, LLC's holdings in Amneal Pharmaceuticals, Inc.
No. Savant Capital exited its AMRX (Amneal Pharmaceuticals) position in Q2 2024. Its Q1 2024 13F listed 10,938 shares worth $66,285. Savant Capital first reported AMRX in Q1 2024 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.